Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis

• DOI: 10.1016/j.jstrokecerebrovasdis.2021.106297
• Publication Date: 2022-01-13T06:00:53Z
• Authors: Marialaura Simonetto; Stephanie Rutrick; Natalie M. LeMoss; Kelsey N. Lansdale; Scott T. Tagawa; Hooman Kamel; Neal Parikh; Babak B. Navi
• Keywords: Lung Neoplasms; Breast Neoplasms; United States; 3. Good health; Stroke; 03 medical and health sciences; Cross-Sectional Studies; 0302 clinical medicine; Practice Guidelines as Topic; Humans; Female; Guideline Adherence; Survivors; Colorectal Neoplasms; Early Detection of Cancer

Cancer can present as stroke. Several cancer types have established screening guidelines. We investigated adherence to guideline-recommended cancer screening in stroke survivors versus the general population.We performed a cross-sectional analysis using 2012-2018 data from the CDC's Behavioral Risk Factor Surveillance System (BRFSS) survey. BRFSS is a nationally-representative telephone survey of non-institutionalized Americans that collects data about health conditions and behaviors, including cancer screening. We defined guideline-recommended colorectal, lung, and breast cancer screening based on the U.S. Preventive Services Task Force recommendations. We used survey-specific methods to estimate up-to-date screening rates for those with and without prior stroke. We used logistic regression to estimate the odds of up-to-date screening in stroke survivors compared to those without history of stroke after adjustment for potential confounders.Among 1,018,440 respondents eligible for colorectal cancer screening, 66% were up-to-date. Among 6,880 respondents eligible for lung cancer screening, 16% were up-to-date. Among 548,434 women eligible for breast cancer screening, 78% were up-to-date. After adjustment for demographics and confounders, stroke survivors were more likely to have up-to-date colorectal cancer screening (OR, 1.10; 95% CI, 1.05-1.16), equally likely to undergo lung cancer screening (OR, 0.99; 95% CI, 0.62-1.59), and less likely to undergo breast cancer screening (OR, 0.87; 95% CI, 0.80-0.94).In a nationwide analysis, stroke survivors had similar suboptimal adherence to guideline-recommended cancer screening as the general population.